In contrast, hormone-receptor positive (HR+) breast cancers typically share a luminal transcriptional profile, which is often estrogen-dependent and enriched in GATA3 mutations with lower mutation rates of TP53 [18]. The gene discussed is TP53; the disease is breast cancer.